Küster, M. M., Schneider, M., Richter, A. M., Richtmann, S., Winter, H., Kriegsmann, M., . . . Dammann, R. H. (2020). Epigenetic inactivation of the tumor suppressor IRX1 occurs frequently in lung sdenocarcinoma and its silencing is sssociated with impaired prognosis. Cancers, 12(12), . https://doi.org/10.3390/cancers12123528
Chicago-Zitierstil (17. Ausg.)Küster, Miriam M., et al. "Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Sdenocarcinoma and Its Silencing Is Sssociated with Impaired Prognosis." Cancers 12, no. 12 (2020). https://doi.org/10.3390/cancers12123528.
MLA-Zitierstil (9. Ausg.)Küster, Miriam M., et al. "Epigenetic Inactivation of the Tumor Suppressor IRX1 Occurs Frequently in Lung Sdenocarcinoma and Its Silencing Is Sssociated with Impaired Prognosis." Cancers, vol. 12, no. 12, 2020, https://doi.org/10.3390/cancers12123528.